These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Approach to the evaluation of the GH/IGF-axis in patients with pituitary disease: which test to order. Roberts B; Katznelson L Pituitary; 2007; 10(2):205-11. PubMed ID: 17429594 [TBL] [Abstract][Full Text] [Related]
6. Pitfalls of insulin-like growth factor-i and growth hormone assays. Junnila RK; Strasburger CJ; Bidlingmaier M Endocrinol Metab Clin North Am; 2015 Mar; 44(1):27-34. PubMed ID: 25732639 [TBL] [Abstract][Full Text] [Related]
7. Serum IGF-I levels in the diagnosis and monitoring of acromegaly. Brooke AM; Drake WM Pituitary; 2007; 10(2):173-9. PubMed ID: 17431794 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic challenges in acromegaly: a case-based review. Bonert V Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23 Suppl 1():S23-30. PubMed ID: 20129191 [TBL] [Abstract][Full Text] [Related]
9. Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study. Bonert V; Carmichael J; Wu Z; Mirocha J; Perez DA; Clarke NJ; Reitz RE; McPhaul MJ; Mamelak A Pituitary; 2018 Feb; 21(1):65-75. PubMed ID: 29218459 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone measurements in the diagnosis and monitoring of acromegaly. Sata A; Ho KK Pituitary; 2007; 10(2):165-72. PubMed ID: 17458702 [TBL] [Abstract][Full Text] [Related]
11. Measuring growth hormone and insulin-like growth factor-I in infants: what is normal? Hawkes CP; Grimberg A Pediatr Endocrinol Rev; 2013 Dec; 11(2):126-46. PubMed ID: 24575549 [TBL] [Abstract][Full Text] [Related]
12. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population. Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002 [TBL] [Abstract][Full Text] [Related]
13. Laboratory investigation of acromegaly: is basal or random GH > 0.4 µg/L in the presence of normal serum IGF-1 an important result? Rosario PW; Calsolari MR Arch Endocrinol Metab; 2015 Feb; 59(1):54-8. PubMed ID: 25926115 [TBL] [Abstract][Full Text] [Related]
14. Pitfalls of insulin-like growth factor I assays. Bidlingmaier M Horm Res; 2009 Jan; 71 Suppl 1():30-3. PubMed ID: 19153502 [TBL] [Abstract][Full Text] [Related]
15. Review of Cortina criteria for the diagnosis of acromegaly. degli Uberti EC; Bondanelli M; Ambrosio MR; Zatelli MC J Endocrinol Invest; 2005; 28(11 Suppl International):70-2. PubMed ID: 16625849 [TBL] [Abstract][Full Text] [Related]
16. Problems with GH assays and strategies toward standardization. Bidlingmaier M Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S41-4. PubMed ID: 18819944 [TBL] [Abstract][Full Text] [Related]
17. Clinical laboratory indices in the treatment of acromegaly. Clemmons DR Clin Chim Acta; 2011 Feb; 412(5-6):403-9. PubMed ID: 21075098 [TBL] [Abstract][Full Text] [Related]
18. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444 [TBL] [Abstract][Full Text] [Related]
19. Dynamic tests and basal values for defining active acromegaly. Tzanela M Neuroendocrinology; 2006; 83(3-4):200-4. PubMed ID: 17047383 [TBL] [Abstract][Full Text] [Related]
20. The challenges of reliance on insulin-like growth factor I in monitoring disease activity in patients with acromegaly. Paisley AN; Trainer PJ Horm Res; 2004; 62 Suppl 1():83-8. PubMed ID: 15761238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]